Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of docetaxel and oxaliplatin in treating
patients who have metastatic or recurrent solid tumor.